Target Name: PLA1A
NCBI ID: G51365
Review Report on PLA1A Target / Biomarker Content of Review Report on PLA1A Target / Biomarker
PLA1A
Other Name(s): Phospholipase A1 member A (isoform 1) | Phospholipase A1 member A | phospholipase A1 member A | PLA1A_HUMAN | Phosphatidylserine-specific phospholipase A1 | phosphatidylserine-specific phospholipase A1alpha | PLA1A variant 1 | Phospholipase A1 member A, transcript variant 1 | Phosphatidylserine-specific phospholipase A1alpha | PSPLA1 | PS-PLA1

PLA1: A Potential Drug Target for Phospholipid Production and Cell Signaling

PLA1A (Phospholipase A1 member A (isoform 1)) is a protein that is expressed in various cell types, including neurons, endothelial cells, and liver cells. It is a potent enzyme that is involved in the process of phospholipase A1 (PLA1), which is a critical step in the production of phospholipids. PLA1 is an enzyme that is responsible for breaking down phospholipids, which are the building blocks of cell membranes.

PLA1 has been identified as a potential drug target due to its involvement in the production of phospholipids, which are critical for maintaining the integrity of cell membranes. Phospholipids are also involved in various signaling pathways, including the regulation of cell signaling pathways, such as the signaling pathway that regulates cell growth and differentiation.

In addition to its involvement in the production of phospholipids, PLA1 has also been shown to play a role in the regulation of various cellular processes, including cell signaling, cell migration, and cell adhesion. PLA1 has also been shown to play a role in the regulation of inflammation, and has been shown to have anti-inflammatory effects.

PLA1 has also been shown to be involved in the production of various signaling molecules, including inositol, which is a critical signaling molecule in the regulation of cell signaling pathways. Inositol plays a role in the regulation of various cellular processes, including cell signaling, cell migration, and cell adhesion.

In conclusion, PLA1 is a protein that has been shown to play a critical role in the production of phospholipids and various signaling molecules. As a potential drug target, PLA1 is a promising target for the development of new pharmaceuticals for the treatment of various diseases, including cancer, neurodegenerative diseases, and inflammatory diseases. Further research is needed to fully understand the role of PLA1 in the regulation of cellular processes and its potential as a drug target.

Protein Name: Phospholipase A1 Member A

Functions: Hydrolyzes the ester bond of the acyl group attached at the sn-1 position of phosphatidylserines (phospholipase A1 activity) and 1-acyl-2-lysophosphatidylserines (lysophospholipase activity) in the pathway of phosphatidylserines acyl chain remodeling (PubMed:10196188). Cleaves phosphatidylserines exposed on the outer leaflet of the plasma membrane of apoptotic cells producing 2-acyl-1-lysophosphatidylserines, which in turn enhance mast cell activation and histamine production (By similarity). Has no activity toward other glycerophospholipids including phosphatidylcholines, phosphatidylethanolamines, phosphatidic acids or phosphatidylinositols, or glycerolipids such as triolein (By similarity)

The "PLA1A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLA1A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PLA2G10 | PLA2G12A | PLA2G12AP1 | PLA2G12B | PLA2G15 | PLA2G1B | PLA2G2A | PLA2G2C | PLA2G2D | PLA2G2E | PLA2G2F | PLA2G3 | PLA2G4A | PLA2G4B | PLA2G4C | PLA2G4D | PLA2G4E | PLA2G4F | PLA2G5 | PLA2G6 | PLA2G7 | PLA2R1 | PLAA | PLAAT1 | PLAAT2 | PLAAT3 | PLAAT4 | PLAAT5 | PLAC1 | PLAC4 | PLAC8 | PLAC8L1 | PLAC9 | PLAC9P1 | PLAG1 | PLAGL1 | PLAGL2 | Plasma Membrane Calcium ATPase | PLAT | Platelet Glycoprotein Ib Complex | Platelet-activating factor acetylhydrolase isoform 1B complex | Platelet-Derived Growth Factor (PDGF) | Platelet-Derived Growth Factor Receptor | PLAU | PLAUR | PLB1 | PLBD1 | PLBD1-AS1 | PLBD2 | PLCB1 | PLCB2 | PLCB3 | PLCB4 | PLCD1 | PLCD3 | PLCD4 | PLCE1 | PLCE1-AS2 | PLCG1 | PLCG1-AS1 | PLCG2 | PLCH1 | PLCH2 | PLCL1 | PLCL2 | PLCXD1 | PLCXD2 | PLCXD3 | PLCZ1 | PLD1 | PLD2 | PLD3 | PLD4 | PLD5 | PLD6 | PLEC | PLEK | PLEK2 | PLEKHA1 | PLEKHA2 | PLEKHA3 | PLEKHA4 | PLEKHA5 | PLEKHA6 | PLEKHA7 | PLEKHA8 | PLEKHA8P1 | PLEKHB1 | PLEKHB2 | PLEKHD1 | PLEKHF1 | PLEKHF2 | PLEKHG1 | PLEKHG2 | PLEKHG3 | PLEKHG4 | PLEKHG4B | PLEKHG5 | PLEKHG6 | PLEKHG7